Suppliers / Zhejiang Wild Wind Pharmaceutical Co., Ltd

Zhejiang Wild Wind Pharmaceutical Co., Ltd

China Updated 9 July 2026

Zhejiang Wild Wind Pharmaceutical Co., Ltd is an API manufacturer based in China. It holds 4 active US drug master files across a filed portfolio of 4 molecules. Its GMP standing is certified by MFDS (Korea) and EMA.

4
active US DMFs
0
valid CEPs
2
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Dongyang, China Not on file
China, China 3006230668

What they file, and where

Molecule Regulators Docs
Levodopa SFDA (Saudi Arabia), US FDA 2
Carbidopa US FDA 1
Caspofungin US FDA 1
Methyldopa US FDA 1

Also appears on these molecule pages

Carbidopa API Caspofungin API Levodopa API

Filings and GMP by regulator

Regulator Filings GMP certificates
MFDS (Korea) None 2
EMA None 1

Questions about Zhejiang Wild Wind Pharmaceutical Co., Ltd

Does Zhejiang Wild Wind Pharmaceutical Co., Ltd hold a US DMF or a CEP?
Zhejiang Wild Wind Pharmaceutical Co., Ltd holds 4 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Zhejiang Wild Wind Pharmaceutical Co., Ltd FDA-registered?
One site operated by Zhejiang Wild Wind Pharmaceutical Co., Ltd carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
Where does Zhejiang Wild Wind Pharmaceutical Co., Ltd manufacture?
2 registered sites are on record, in China (Dongyang and China). Every site is listed on this page with the register it came from.
What does Zhejiang Wild Wind Pharmaceutical Co., Ltd make?
4 molecules are on record against Zhejiang Wild Wind Pharmaceutical Co., Ltd, including Levodopa, Carbidopa, Caspofungin and Methyldopa. Each links through to that molecule's full manufacturer list.
Which regulators recognise Zhejiang Wild Wind Pharmaceutical Co., Ltd's GMP?
Current GMP certificates are on record from MFDS (Korea) and EMA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Zhejiang Wild Wind Pharmaceutical Co., Ltd comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Hetero shares 2 molecules Maithri Drugs shares 2 molecules Divi's Laboratories shares 2 molecules Shandong Xinhua Pharmaceutical shares 2 molecules Zhejiang Yongtai Chiral Medicine Technology shares 2 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates